Table 30.
Trial | Lesions due to | UUC | IUC | IT40 |
---|---|---|---|---|
AST‐6 | E. acervulina | 0.2c | 2.4a | 1.7b |
E. maxima | 0.2b | 0.7a | 0.2b | |
AST‐71 | E. acervulina | 0.1b/0.1c | 2.5a/2.1a | 2.2a/1.6b |
E. tenella | 0.0c/0.0c | 2.5a/1.9a | 1.9b/1.2b | |
AST‐8 | E. acervulina | 0.7c | 2.7a | 1.5b |
E. tenella | 0.2b | 0.6a | 0.2b | |
E. maxima | 0.5b | 1.0a | 0.6b | |
AST‐9 | E. maxima | 0.4b | 2.5a | 0.5b |
AST‐11 | E. acervulina | 0.3c | 2.8a | 1.4b |
E. maxima | 0.4b | 0.9a | 0.5b | |
AST‐12 | E. tenella | 0.1c | 1.2a | 0.6b |
Means with different superscript letter in a row of the same trial (and of the same sex) are significantly different (p < 0.05).
Female/male.